Loading insider details...
Beta
Latest Form 4 (Jun 18, 2026): Grant/Award of 25,319 CGEM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 18, 2026 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 25,319 | n/a |
| Jun 16, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 9,810 | n/a |
| Jun 12, 2026 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 19,000 | n/a |
| Oct 28, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 53,521 | n/a |
| Jun 12, 2025 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 19,000 | n/a |
| Feb 27, 2025 | Q32 Bio Inc. (QTTB) | Disposition to Issuer | 12,767 | n/a |
| Aug 9, 2024 | Cullinan Therapeutics, Inc. (CGEM) | Grant/Award | 25,743 | n/a |
| Jun 14, 2024 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 16,000 | n/a |
| Jun 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Grant/Award | 18,068 | n/a |
| May 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Disposition to Issuer | 24,309 | n/a |